ACE and hydrops fetalis: Since the HF patient is on several other HF medications, in addition to angiotensin-converting-enzyme inhibitors (ACEI) and β-blockers, including angiotensin receptor blockers, aldosterone-antagonists, hydralazine, and isosorbide, hypotension has been reported as adverse events in 6–8% of patients [28].